A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder

NCT00501267 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: solabegron and oxybutynin

Sponsor

GlaxoSmithKline